查看購物車
  • Simplified Chinese
  • English
歐洲細胞和基因治療市場預測（2031年）-區域分析-按類型、服務、規模、服務提供者和最終用戶
市場調查報告書
商品編碼
1764843

歐洲細胞和基因治療市場預測（2031年）-區域分析-按類型、服務、規模、服務提供者和最終用戶

Europe Cell and Gene Therapy Market Forecast to 2031 - Regional Analysis - by Type, Services, Scale, Service Providers, and End User
出版日期: | 出版商: The Insight Partners | 英文 163 Pages | 訂單完成後即時交付

價格

2023 年歐洲細胞和基因治療市場價值為 11.051 億美元，預計到 2031 年將達到 53.3444 億美元；預計 2023 年至 2031 年的複合年成長率為 21.7%。

外包細胞和基因治療製造的快速普及推動了歐洲細胞和基因治療市場的發展

細胞和基因療法的生產是一個複雜的過程，因此正確執行和監控操作至關重要。細胞和基因療法製造商擁有精通生物和製程工程的合格人員數量有限。此外，對於經驗豐富的團隊來說，使用手動和開放式生產方法管理首次臨床試驗的嘗試，以及建立更符合商業需求的流程，可能極具挑戰性。因此，這些製造商選擇與合約開發和生產組織 (CDMO) 合作，以加快其臨床研究和商業化。 CDMO 以合約方式為細胞和基因療法公司提供產品開發、生產、臨床試驗和商業化服務。與 CDMO 合作，細胞和基因療法製造商能夠實現可擴展性、加快上市速度、無需支付管理費用即可獲得技術專業知識，並提高成本效益。事實證明，將細胞和基因療法的生產外包給 CDMO 對製造商而言具有成本效益。他們可以獲得 CDMO 先進的技術基礎設施和專業知識。 CDMO 採用適當的、規劃好的流程來生產細胞和基因療法。因此，越來越傾向於將不斷成長的細胞和基因治療製造外包給 CDMO，這推動了歐洲細胞和基因治療市場的成長。

歐洲細胞與基因治療市場概況

由於對生產能力建設的投資、政府的大力支持以及對該地區的參與等因素，預計德國的細胞和基因治療市場將在預測期內顯著成長。此外，頂級競爭對手的存在將在預測期內增強區域市場的成長。德國擁有強大的製藥業，特別注重研發。該國擁有 660 家生物技術公司，僱用了 50,000 名員工。其中，660 家公司專注於細胞和基因療法 (CGT)。根據 NecstGen 的報告，2023 年有超過 29 項評估 CAR 修飾免疫細胞的活躍臨床試驗正在進行中，且大多數生產涉及 CAR-T 細胞。此外，到目前為止，德國已經在基因治療領域進行了 50 多項臨床研究。德國 CGT 公司的創新工作主要集中在地方或國家層面，因為它們缺乏國際影響力。

歐洲細胞和基因治療市場收入及預測（2031年）（百萬美元）

歐洲細胞和基因治療市場細分

歐洲細胞和基因治療市場分為類型、服務、規模、最終用戶和國家。

根據類型，歐洲細胞和基因治療市場分為細胞治療和基因治療。 2023年，細胞治療佔據了更大的市場。此外，細胞治療細分市場又細分為同種異體載體、自體載體和病毒載體。基因治療細分市場又細分為非病毒載體和病毒載體。

就服務而言，歐洲細胞和基因治療市場分為製程開發、cGMP製造、監管服務和生物測定服務。製程開發領域在2023年佔據了最大的市場。

依規模分類，歐洲細胞和基因治療市場分為商業化前/研發生產和商業化規模生產。 2023年，商業化前/研發生產領域佔據了更大的市場佔有率。

根據最終用戶，歐洲細胞和基因治療市場細分為合約研究組織、製藥和生物製藥公司以及學術和研究機構。製藥和生物製藥公司在2023年佔據了最大的市場。

按國家/地區分類，歐洲細胞和基因治療市場分為英國、德國、法國、義大利、西班牙和歐洲其他地區。 2023年，德國佔據了歐洲細胞和基因治療市場佔有率的主導地位。

Catalent Inc、Cell and Gene Therapy Catapult、Charles River Laboratories International Inc、F. Hoffmann-La Roche Ltd、FUJIFILM Holdings Corp、Lonza Group AG、Lotte Corp、Merck KGaA、Takara Bio Inc、Thermo Fisher Scientific Inc. 和無錫藥明康德股份有限公司是一些歐洲細胞和基因治療市場的領先公司。

目錄

第1章：簡介

第2章：執行摘要

  • 關鍵見解

第3章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第4章：歐洲細胞與基因治療市場格局

  • 概述
  • PEST分析

第5章：歐洲細胞與基因治療市場－關鍵市場動態

  • 細胞與基因治療市場—關鍵市場動態
  • 市場促進因素
    • 細胞和基因療法獲批數量的增加
    • 外包細胞與基因治療製造迅速普及
  • 市場限制
    • 細胞和基因治療製造成本高昂
  • 市場機會
    • 企業的策略舉措
  • 未來趨勢
    • 細胞和基因治療製造服務的自動化
  • 促進因素和限制因素的影響：

第6章：細胞與基因治療市場-歐洲市場分析

  • 歐洲概況
  • 2021-2031年歐洲細胞與基因治療市場收入
  • 歐洲細胞和基因治療市場預測分析

第7章：歐洲細胞與基因治療市場分析－依類型

  • 細胞療法
  • 基因治療

第8章：歐洲細胞與基因治療市場分析-按服務

  • 製程開發
  • cGMP 製造
  • 監管服務
  • 生物測定服務

第9章：歐洲細胞與基因治療市場分析－依規模

  • 商業化前/研發製造
  • 商業規模生產

第 10 章：歐洲細胞和基因治療市場分析 - 按服務提供者

  • 合約製造與生產組織
  • 首席行銷長

第 11 章：歐洲細胞和基因治療市場分析 - 按最終用戶

  • 合約研究組織
  • 製藥和生物製藥公司
  • 學術和研究機構

第 12 章：歐洲細胞與基因治療市場 - 國家分析

  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 歐洲其他地區

第13章：產業格局

  • 概述
  • 細胞和基因治療市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 14 章：公司簡介

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Charles River Laboratories International Inc
  • Cell and Gene Therapy Catapult
  • Lonza Group AG
  • WuXi AppTec Co Ltd
  • Takara Bio Inc
  • FUJIFILM Holdings Corp
  • F. Hoffmann-La Roche Ltd
  • Catalent Inc
  • Lotte Corp

第 15 章：附錄

Product Code: BMIRE00031471

The Europe cell and gene therapy market was valued at US$ 1,105.10 million in 2023 and is projected to reach US$ 5,334.44 million by 2031; it is estimated to record a CAGR of 21.7% from 2023 to 2031.

Rapid Popularity of Outsourcing Cell and Gene Therapy Manufacturing Drives Europe Cell and Gene Therapy Market

Cell and gene therapy manufacturing is a complex process, which makes the proper execution and monitoring of the operation crucial. Cell and gene therapy manufacturers have a limited number of qualified personnel who know biological and process engineering. Moreover, for experienced teams, managing the attempts to reach the first clinical trial using a manual and open manufacturing method, as well as building a more commercially suitable process, can be challenging. Therefore, these manufacturers choose to work with contract development and manufacturing organizations (CDMOs) to accelerate their clinical studies and commercialization process. CDMOs support product development, manufacturing, clinical trials, and commercialization services to cell and gene therapy companies on a contract basis. Under the partnership with a CDMO, cell and gene therapy manufacturers support scalability, speed to market, access to technical expertise without overhead costs, and cost efficiencies. Outsourcing cell and gene therapy manufacturing to CDMOs proves to be cost-effective for manufacturers. They gain access to the technologically advanced infrastructure and expertise of CDMOs. CDMOs employ proper, mapped processes for manufacturing cell and gene therapies. Thus, the increasing preference for outsourcing growing cell and gene therapy manufacturing to CDMOs fuels the Europe cell and gene therapy market growth.

Europe Cell and Gene Therapy Market Overview

The cell and gene therapy market in Germany is expected to witness significant growth during the forecast period due to factors such as investment in the setup of production capacity, high government support, and involvement in the region. Also, the presence of top competitive players will enhance the regional market growth during the forecast period. Germany has a strong pharmaceutical industry with a notable focus on R&D. The country has 660 biotechnology companies that employ 50,000 employees. Among these, 660 companies are focused on cell and gene therapies (CGTs). As per the NecstGen report, more than 29 active clinical trials evaluating CAR-modified immune cells were ongoing in 2023, and most of the production involved CAR-T cells. Also, over 50 clinical studies have been conducted in gene therapy in Germany so far. The innovation efforts of German CGT companies are majorly focused on the local or country level, as they lack international presence.

Europe Cell and Gene Therapy Market Revenue and Forecast to 2031 (US$ Million)

Europe Cell and Gene Therapy Market Segmentation

The Europe cell and gene therapy market is categorized into type, services, scale, end user, and country.

Based on type, the Europe cell and gene therapy market is bifurcated into cell therapy and gene therapy. The cell therapy segment held a larger market share in 2023. Furthermore, the cell therapy segment is sub segmented into allogeneic, autologous, viral vectors. Additionally, the gene therapy segment is divided into non-viral vectors and viral vectors.

In terms of services, the Europe cell and gene therapy market is categorized process development, cGMP manufacturing, regulatory services, and bioassay services. The process development segment held the largest market share in 2023.

By scale, the Europe cell and gene therapy market is bifurcated into pre-commercial/R&D manufacturing and commercial scale manufacturing. The pre-commercial/R&D manufacturing segment held a larger market share in 2023.

Based on end user, the Europe cell and gene therapy market is segmented into contract research organizations, pharmaceutical and biopharmaceutical companies, and academic and research institutes. The pharmaceutical and biopharmaceutical companies segment held the largest market share in 2023.

By country, the Europe cell and gene therapy market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe cell and gene therapy market share in 2023.

Catalent Inc, Cell and Gene Therapy Catapult, Charles River Laboratories International Inc, F. Hoffmann-La Roche Ltd, FUJIFILM Holdings Corp, Lonza Group AG, Lotte Corp, Merck KGaA, Takara Bio Inc, Thermo Fisher Scientific Inc., and WuXi AppTec Co Ltd are some of the leading companies operating in the Europe cell and gene therapy market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Europe Cell and Gene Therapy Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Europe Cell and Gene Therapy Market - Key Market Dynamics

  • 5.1 Cell and Gene Therapy Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increase in Number of Approval of Cell and Gene Therapies
    • 5.2.2 Rapid Popularity of Outsourcing Cell and Gene Therapy Manufacturing
  • 5.3 Market Restraints
    • 5.3.1 High Cost of Cell and Gene Therapy Manufacturing
  • 5.4 Market Opportunities
    • 5.4.1 Strategic Initiatives by Companies
  • 5.5 Future Trends
    • 5.5.1 Automation of Cell and Gene Therapy Manufacturing Services
  • 5.6 Impact of Drivers and Restraints:

6. Cell and Gene Therapy Market -Europe Market Analysis

  • 6.1 Overview Europe
  • 6.2 Europe Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031
  • 6.3 Europe Cell and Gene Therapy Market Forecast Analysis

7. Europe Cell and Gene Therapy Market Analysis - by Type

  • 7.1 Cell Therapy
    • 7.1.1 Overview
    • 7.1.2 Cell Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Gene Therapy
    • 7.2.1 Overview
    • 7.2.2 Gene Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Cell and Gene Therapy Market Analysis - by Services

  • 8.1 Process Development
    • 8.1.1 Overview
    • 8.1.2 Process Development: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 cGMP Manufacturing
    • 8.2.1 Overview
    • 8.2.2 cGMP Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Regulatory Services
    • 8.3.1 Overview
    • 8.3.2 Regulatory Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Bioassay Services
    • 8.4.1 Overview
    • 8.4.2 Bioassay Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Cell and Gene Therapy Market Analysis - by Scale

  • 9.1 Pre-Commercial/R&D Manufacturing
    • 9.1.1 Overview
    • 9.1.2 Pre-Commercial/R&D Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Commercial Scale Manufacturing
    • 9.2.1 Overview
    • 9.2.2 Commercial Scale Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

10. Europe Cell and Gene Therapy Market Analysis - by Service Providers

  • 10.1 CDMOs
    • 10.1.1 Overview
    • 10.1.2 CDMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 CMOs
    • 10.2.1 Overview
    • 10.2.2 CMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

11. Europe Cell and Gene Therapy Market Analysis - by End User

  • 11.1 Contract Research Organizations
    • 11.1.1 Overview
    • 11.1.2 Contract Research Organizations: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.2 Pharmaceutical and Biopharmaceutical Companies
    • 11.2.1 Overview
    • 11.2.2 Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.3 Academic and Research Institutes
    • 11.3.1 Overview
    • 11.3.2 Academic and Research Institutes: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

12. Europe Cell and Gene Therapy Market - Country Analysis

  • 12.1 Europe Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    • 12.1.1 Europe Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
      • 12.1.1.1 Europe Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
      • 12.1.1.2 United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.2.1 United Kingdom: Cell and Gene Therapy Market Breakdown, by Type
          • 12.1.1.2.1.1 United Kingdom: Cell and Gene Therapy Market Breakdown, by Cell Therapy
          • 12.1.1.2.1.2 United Kingdom: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.1.1.2.2 United Kingdom: Cell and Gene Therapy Market Breakdown, by Services
        • 12.1.1.2.3 United Kingdom: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.1.1.2.4 United Kingdom: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.1.1.2.5 United Kingdom: Cell and Gene Therapy Market Breakdown, by End User
      • 12.1.1.3 Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.3.1 Germany: Cell and Gene Therapy Market Breakdown, by Type
          • 12.1.1.3.1.1 Germany: Cell and Gene Therapy Market Breakdown, by Cell Therapy
          • 12.1.1.3.1.2 Germany: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.1.1.3.2 Germany: Cell and Gene Therapy Market Breakdown, by Services
        • 12.1.1.3.3 Germany: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.1.1.3.4 Germany: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.1.1.3.5 Germany: Cell and Gene Therapy Market Breakdown, by End User
      • 12.1.1.4 France: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.4.1 France: Cell and Gene Therapy Market Breakdown, by Type
          • 12.1.1.4.1.1 France: Cell and Gene Therapy Market Breakdown, by Cell Therapy
          • 12.1.1.4.1.2 France: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.1.1.4.2 France: Cell and Gene Therapy Market Breakdown, by Services
        • 12.1.1.4.3 France: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.1.1.4.4 France: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.1.1.4.5 France: Cell and Gene Therapy Market Breakdown, by End User
      • 12.1.1.5 Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.5.1 Italy: Cell and Gene Therapy Market Breakdown, by Type
          • 12.1.1.5.1.1 Italy: Cell and Gene Therapy Market Breakdown, by Cell Therapy
          • 12.1.1.5.1.2 Italy: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.1.1.5.2 Italy: Cell and Gene Therapy Market Breakdown, by Services
        • 12.1.1.5.3 Italy: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.1.1.5.4 Italy: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.1.1.5.5 Italy: Cell and Gene Therapy Market Breakdown, by End User
      • 12.1.1.6 Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.6.1 Spain: Cell and Gene Therapy Market Breakdown, by Type
          • 12.1.1.6.1.1 Spain: Cell and Gene Therapy Market Breakdown, by Cell Therapy
          • 12.1.1.6.1.2 Spain: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.1.1.6.2 Spain: Cell and Gene Therapy Market Breakdown, by Services
        • 12.1.1.6.3 Spain: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.1.1.6.4 Spain: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.1.1.6.5 Spain: Cell and Gene Therapy Market Breakdown, by End User
      • 12.1.1.7 Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.7.1 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Type
          • 12.1.1.7.1.1 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Cell Therapy
          • 12.1.1.7.1.2 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Gene Therapy
        • 12.1.1.7.2 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Services
        • 12.1.1.7.3 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Scale
        • 12.1.1.7.4 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Service Providers
        • 12.1.1.7.5 Rest of Europe: Cell and Gene Therapy Market Breakdown, by End User

13. Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in Cell and Gene Therapy Market
  • 13.3 Organic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Inorganic Growth Strategies
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 Thermo Fisher Scientific Inc.
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Merck KGaA
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Charles River Laboratories International Inc
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Cell and Gene Therapy Catapult
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Lonza Group AG
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 WuXi AppTec Co Ltd
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Takara Bio Inc
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 FUJIFILM Holdings Corp
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 F. Hoffmann-La Roche Ltd
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Catalent Inc
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments
  • 14.11 Lotte Corp
    • 14.11.1 Key Facts
    • 14.11.2 Business Description
    • 14.11.3 Products and Services
    • 14.11.4 Financial Overview
    • 14.11.5 SWOT Analysis
    • 14.11.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. Cell and Gene Therapy Market Segmentation
  • Table 2. Europe Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 4. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Cell Therapy
  • Table 5. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Gene Therapy
  • Table 6. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Services
  • Table 7. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Scale
  • Table 8. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by Service Providers
  • Table 9. Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 10. Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 11. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 12. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 13. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 14. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 15. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 16. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 17. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 18. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 19. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 20. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 21. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 22. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 23. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 24. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 25. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 26. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 27. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 28. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 29. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 30. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 31. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 32. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 33. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 34. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 35. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 36. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 37. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 38. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 39. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 40. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 41. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 42. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 43. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 44. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 45. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 46. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 47. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Cell Therapy
  • Table 48. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Gene Therapy
  • Table 49. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Services
  • Table 50. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Scale
  • Table 51. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by Service Providers
  • Table 52. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 53. Recent Organic Growth Strategies in Cell and Gene Therapy Market
  • Table 54. Recent Inorganic Growth Strategies in the Cell and Gene Therapy Market
  • Table 55. Glossary of Terms

List Of Figures

  • Figure 1. Cell and Gene Therapy Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031
  • Figure 5. Cell and Gene Therapy Market Share (%) - by Type (2023 and 2031)
  • Figure 6. Cell Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Gene Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Cell and Gene Therapy Market Share (%) - by Services (2023 and 2031)
  • Figure 9. Process Development: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. cGMP Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Regulatory Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Bioassay Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Cell and Gene Therapy Market Share (%) - by Scale (2023 and 2031)
  • Figure 14. Pre-Commercial/R&D Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Commercial Scale Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Cell and Gene Therapy Market Share (%) - by Service Providers (2023 and 2031)
  • Figure 17. CDMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. CMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Cell and Gene Therapy Market Share (%) - by End User (2023 and 2031)
  • Figure 20. Contract Research Organizations: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Academic and Research Institutes: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Europe Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 24. Europe Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 25. United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 26. Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 27. France: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 28. Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 29. Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 30. Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 31. Growth Strategies in Cell and Gene Therapy Market